Tag: Sintilimab

Tag Visualization: Top 50 related tags by occurrence

Medicine: 8 articlesMedicineClinical medicine: 13 articlesClinical medicineChina: 16 articlesChinaBiotechnology: 13 articlesBiotechnologyPharmaceutical industry: 1 articlePharm...Health care: 3 articlesHealth car...Eli Lilly and Company: 10 articlesEli Lilly and Comp...Immunology: 7 articlesImmunologySanofi: 2 articlesSanofiIncyte: 2 articlesIncyteCancer treatments: 6 articlesCancer treatme...Virotherapy: 2 articlesVirother...Immune system: 5 articlesImmune systemSpecialty drugs: 8 articlesSpecialty drugsMonoclonal antibodies: 4 articlesMonoclonal ...Tumor microenvironment: 2 articlesTumor mi...Monoclonal antibody therapy: 2 articlesMonoclon...Cancer immunotherapy: 17 articlesCancer immunotherapyBiopharmaceutical: 8 articlesBiopharmaceutica...Biosimilar: 9 articlesBiosimilarDrugs: 7 articlesDrugsBevacizumab: 6 articlesBevacizumabAdalimumab: 4 articlesAdalimumabOrphan drugs: 4 articlesOrphan drug...Rituximab: 3 articlesRituximabKRAS: 1 articleKRASLung cancer: 2 articlesLung can...Life Sciences: 9 articlesLife SciencesProgrammed cell death protein 1: 2 articlesProgramm...Health sciences: 3 articlesHealth sci...Checkpoint inhibitor: 3 articlesCheckpoint...CD47: 1 articleCD47Targeted therapy: 2 articlesTargeted...Medical specialties: 4 articlesMedical spe...Angiogenesis inhibitors: 2 articlesAngiogen...Clusters of differentiation: 3 articlesClusters o...BioInvent International AB: 1 articleBioIn...PD-L1: 2 articlesPD-L1Hodgkin lymphoma: 1 articleHodgk...Non-small-cell lung carcinoma: 3 articlesNon-small-...Mantle cell lymphoma: 1 articleMantl...Bolt Biotherapeutics, Inc.: 2 articlesBolt Bio...Pemetrexed: 2 articlesPemetrex...HANG SENG COMPOSITE INDEX: 1 articleHANG ...TIGIT: 1 articleTIGITAscentage Pharma: 1 articleAscen...Sintilimab: 20 articlesSintilimabInnovent Biologics Inc.: 18 articlesInnovent Biologics Inc.1801.HK: 1 article1801....Innovent Biologics: 1 articleInnov...

Recent Related Articles to Sintilimab

Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI321 (Anti-PD-1/TIGIT ...

Added to Collection on: 2021-07-26 00:00:00

Tags for this article:

Life Sciences
Clinical medicine
Medicine
Biotechnology
Immune system
Cancer immunotherapy
Clusters of differentiation
Specialty drugs
Sintilimab
Biosimilar
TIGIT
Adalimumab
China
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Significant Weight Loss and Multiple Metabolic Benefits: Phase 1b Study Results of IBI362 in ...

Added to Collection on: 2021-08-18 00:13:36

Tags for this article:

Drugs
Clinical medicine
Medicine
Cancer immunotherapy
Sintilimab
Anti-obesity medication
Oxyntomodulin
Biosimilar
Diabetes
Medroxyprogesterone acetate
Obesity
Glucagon-like peptide-1 receptor
GLP-1
Innovent Biologics Inc.
Hongwei Jiang
Glucagon
Lei Qian
Linong Ji
China

Click the tags to see associated articles and topics

View Article Details
Bolt Biotherapeutics and Innovent Biologics Announce Collaboration to Develop Three New ...

Added to Collection on: 2021-08-26 20:03:45

Tags for this article:

Life Sciences
Clinical medicine
Medicine
Cancer immunotherapy
Biotechnology
Immunology
Virotherapy
Biopharmaceutical
Eli Lilly and Company
Sintilimab
Tumor microenvironment
Monoclonal antibody therapy
Bolt Biotherapeutics, Inc.
China
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Innovent and Bolt Biotherapeutics Announce Collaboration to Develop Three New Oncology ...

Added to Collection on: 2021-08-27 00:00:00

Tags for this article:

Life Sciences
Clinical medicine
Medicine
Biotechnology
Immunology
Cancer immunotherapy
Monoclonal antibodies
Virotherapy
Biopharmaceutical
Sintilimab
Monoclonal antibody therapy
Tumor microenvironment
Bolt Biotherapeutics, Inc.
China
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Innovent Announces First Patient Dosed in a Phase 2 Clinical study of IBI112 (IL ... - PR Newswire

Added to Collection on: 2022-07-04 00:11:17

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Biotechnology
Autoimmune diseases
Monoclonal antibodies
Immunology
Diarrhea
Ulcerative colitis
Sintilimab
Biopharmaceutical
Biosimilar
China
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Sanofi keeps its eye on the China prize with Innovent deal - Evaluate Pharma

Added to Collection on: 2022-08-05 21:05:26

Tags for this article:

Cancer immunotherapy
Sintilimab
Sanofi
Clinical medicine
Health care
Health sciences
Innovent

Click the tags to see associated articles and topics

View Article Details
Innovent Announces First Patient Dosing in Australia in Phase 1 Study of IBI363 (PD-1/IL-2 ...

Added to Collection on: 2022-08-24 10:20:37

Tags for this article:

Medicine
Medical specialties
Clinical medicine
Cancer treatments
Immune system
Sintilimab
Programmed cell death protein 1
PD-L1
Immune checkpoint
Interleukin 2
Immunotherapy
Checkpoint inhibitor
Australia
China
Innovent Biologics Inc.
I Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Innovent's MSCI ESG Rating Upgraded to A - PR Newswire

Added to Collection on: 2023-11-30 23:58:46

Tags for this article:

Biotechnology
Specialty drugs
Cancer immunotherapy
Sintilimab
Eli Lilly and Company
Biosimilar
Biopharmaceutical
MSCI
Incyte
Pharmaceutical industry in India
Bevacizumab
Yu Dechao
Research LLC
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Innovent Announces Retirement of CFO and Appointment of New CFO - Yahoo Finance

Added to Collection on: 2024-02-05 18:34:47

Tags for this article:

Specialty drugs
Orphan drugs
Monoclonal antibodies
Angiogenesis inhibitors
Cancer immunotherapy
Sintilimab
Eli Lilly and Company
Biosimilar
Biopharmaceutical
Incyte
Adalimumab
Bevacizumab
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Innovent Announces 2024 Interim Results and Business Updates - PR Newswire

Added to Collection on: 2024-08-28 16:36:51

Tags for this article:

Cancer immunotherapy
Eli Lilly and Company
Research and development in the United States
Sintilimab
Lung cancer
Non-small-cell lung cancer
KRAS
Sanofi
Innovent Biologics Inc.
China

Click the tags to see associated articles and topics

View Article Details